We are live on ! Find out more
Jane Street

Jane Street Portfolio holdings

AUM $777B
1-Year Est. Return 61.18%
 

Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.

This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+61.18%
3 Year Est. Return
+147.64%
5 Year Est. Return
+157.48%
10 Year Est. Return
+673.77%
AUM
$438B
AUM Growth
-$40.7B
Cap. Flow
-$64.5B
Cap. Flow %
-14.73%
Top 10 Hldgs %
43.02%
Holding
10,566
New
1,468
Increased
4,415
Reduced
3,257
Closed
1,331

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$2.95B
2
NVDA icon
NVIDIA
NVDA
+$1.63B
3
V icon
Visa
V
+$1.09B
4
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$1.05B
5
AMZN icon
Amazon
AMZN
+$917M

Sector Composition

Rank Sector Weight
1 Technology 4.58%
2 Consumer Discretionary 2.07%
3 Financials 1.9%
4 Healthcare 1.47%
5 Industrials 1.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KROS icon
7801
CALL
Keros Therapeutics
KROS
$221M
$288K ﹤0.01%
6,300
-13,600
-68% -$731K
ERNZ
7802
DELISTED
Elevation Series Trust TrueShares Active Yield ETF
ERNZ
$287K ﹤0.01%
+11,557
New +$290K
GFOF
7803
DELISTED
Grayscale Future of Finance ETF
GFOF
$287K ﹤0.01%
15,187
-1,844
-11% -$31.9K
RELY icon
7804
CALL
Remitly
RELY
$5.14B
$287K ﹤0.01%
23,700
-39,800
-63% -$617K
NWL icon
7805
CALL
Newell Brands
NWL
$2.56B
$287K ﹤0.01%
44,800
+300
+0.7% +$2.23K
RHCB
7806
DELISTED
BNY Mellon Responsible Horizons Corporate Bond ETF
RHCB
$287K ﹤0.01%
6,310
-581
-8% -$26.3K
TSHA icon
7807
Taysha Gene Therapies
TSHA
$1.89B
$287K ﹤0.01%
128,124
+69,238
+118% +$201K
CPTL
7808
Global X Funds Global X Morningstar Capital Allocation Leaders ETF
CPTL
$120M
$287K ﹤0.01%
+7,755
New +$279K
NKTX icon
7809
CALL
Nkarta
NKTX
$172M
$286K ﹤0.01%
48,400
-23,900
-33% -$169K
BCS icon
7810
PUT
Barclays
BCS
$94.1B
$286K ﹤0.01%
26,700
+1,500
+6% +$15.6K
FXC icon
7811
Invesco CurrencyShares Canadian Dollar Trust
FXC
$73.6M
$286K ﹤0.01%
+3,994
New +$286K
OLMA icon
7812
CALL
Olema Pharmaceuticals
OLMA
$1.05B
$286K ﹤0.01%
+26,400
New +$286K
DXD icon
7813
ProShares UltraShort Dow 30
DXD
$42.2M
$285K ﹤0.01%
+8,921
New +$291K
SHUS icon
7814
Syntax Stratified US Total Market Hedged ETF
SHUS
$25.3M
$285K ﹤0.01%
+7,069
New +$288K
JANX icon
7815
CALL
Janux Therapeutics
JANX
$967M
$285K ﹤0.01%
+6,800
New +$319K
FVC icon
7816
First Trust Dorsey Wright Dynamic Focus 5 ETF
FVC
$109M
$284K ﹤0.01%
+8,067
New +$275K
AVBP icon
7817
ArriVent BioPharma
AVBP
$1.44B
$284K ﹤0.01%
15,333
-21,626
-59% -$386K
USAP
7818
DELISTED
Universal Stainless & Alloy
USAP
$284K ﹤0.01%
10,382
-82,594
-89% -$2.44M
IDU icon
7819
iShares US Utilities ETF
IDU
$1.36B
$284K ﹤0.01%
+3,234
New +$284K
FSK icon
7820
CALL
FS KKR Capital
FSK
$3.44B
$284K ﹤0.01%
14,400
-46,700
-76% -$918K
IPI icon
7821
Intrepid Potash
IPI
$469M
$284K ﹤0.01%
+12,120
New +$279K
MIRM icon
7822
PUT
Mirum Pharmaceuticals
MIRM
$6.14B
$284K ﹤0.01%
8,300
RWM icon
7823
ProShares Short Russell2000
RWM
$100M
$284K ﹤0.01%
13,628
-50,896
-79% -$1.07M
ARQQ icon
7824
Arqit Quantum
ARQQ
$399M
$283K ﹤0.01%
+33,146
New +$359K
ITIC
7825
Investors Title Co
ITIC
$547M
$283K ﹤0.01%
+1,573
New +$260K

Similar funds

Jane Street's Q2 2024 Portfolio in Review

As of Q2 2024, Jane Street held 10,566 positions worth $438B, down 8.5% from $478B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Jane Street withdrew a net $64.5B in Q2 2024, closing 1,331 positions and reducing 3,257 holdings. Its most notable exit was iShares MSCI EAFE Small-Cap ETF, an estimated $254M position sold in full.

By sector, the portfolio is most concentrated in Technology at 4.6% of assets, up from 2.4% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Jane Street opened a new position in iShares Bitcoin Trust worth $221M.

  • Jane Street's largest Q2 2024 buy was iShares Bitcoin Trust: 6,474,742 shares worth $221M.
  • Jane Street added most to Apple in Q2 2024, an estimated $2.95B increase.
  • Jane Street's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.48B.
  • Jane Street fully exited iShares MSCI EAFE Small-Cap ETF in Q2 2024, selling an estimated $254M.
  • Jane Street's ten largest holdings make up 43% of its $438B portfolio in Q2 2024.
  • Jane Street opened 1,468 new positions and closed 1,331 in Q2 2024.
  • Jane Street's portfolio value fell 8.5% quarter-over-quarter to $438B.

Based on Jane Street's 13F filing for Q2 2024, filed 15 Aug 2024.